BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10948867)

  • 1. Prostate cancer conundrum.
    Thompson I
    Health News; 2000 Aug; 6(8):1-2. PubMed ID: 10948867
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
    Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE
    Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice.
    Sharkey J; Cantor A; Solc Z; Huff W; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R
    Brachytherapy; 2005; 4(1):34-44. PubMed ID: 15737905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
    Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ
    J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer?
    Merrick GS; Butler WM; Lief JH; Dorsey AT
    Tech Urol; 2001 Mar; 7(1):12-9. PubMed ID: 11272667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The latest strategies for treating prostate cancer.
    Johns Hopkins Med Lett Health After 50; 2001 Mar; 13(1):4-5. PubMed ID: 11232479
    [No Abstract]   [Full Text] [Related]  

  • 9. PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy.
    Gacci M; Serni S; Lapini A; Vittori G; Vignolini G; Nesi G; Carini M
    Prostate Cancer Prostatic Dis; 2008; 11(1):99-101. PubMed ID: 17923856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intervention after definitive therapy for localized prostate cancer: results from a pilot study.
    Parsons JK; Newman VA; Mohler JL; Pierce JP; Flatt S; Messer K; Marshall J
    Can J Urol; 2009 Jun; 16(3):4648-54. PubMed ID: 19497171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
    Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
    Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advancement of treatment for prostate cancer].
    Hara I
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):178-82. PubMed ID: 16484852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H; Pedersen KV
    Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350).
    Oton CA
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937
    [No Abstract]   [Full Text] [Related]  

  • 15. The PSA conundrum.
    Vikram B
    Radiother Oncol; 2004 Apr; 71(1):1-2. PubMed ID: 15066289
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
    Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice. Localized prostate cancer.
    Walsh PC; DeWeese TL; Eisenberger MA
    N Engl J Med; 2007 Dec; 357(26):2696-705. PubMed ID: 18160689
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective study of quality of life of patients receiving treatment for prostate cancer.
    Eller LS; Lev EL; Gejerman G; Colella J; Esposito M; Lanteri V; Scheuch J; Munver R; Lane P; Junchaya C; Alves L; Galli B; Watson R; Sawczuk I
    Nurs Res; 2006; 55(2 Suppl):S28-36. PubMed ID: 16601630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen (PSA) in the monitoring of prostate cancer after radical prostatectomy and external beam radiation.
    Schaefer U; Witt F; Schueller P; Micke O; Willich N
    Anticancer Res; 2000; 20(6D):4989-92. PubMed ID: 11326654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.
    Walsh PC
    J Urol; 2000 Oct; 164(4):1322-3. PubMed ID: 10992405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.